Emmerich Ilka Ute
Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät der Universität Leipzig.
Tierarztl Prax Ausg G Grosstiere Nutztiere. 2024 Apr;52(2):96-100. doi: 10.1055/a-2291-7062. Epub 2024 May 3.
In 2023, no new active pharmaceutical ingredients were released on the German market for horses and food-producing animals. Two established veterinary active pharmaceutical ingredients became available for additional species: The phosphorus compound butafosfan was also approved for horses, dogs, and cats and the mineral sodium chloride as an isotonic sodium chloride solution was also approved for rabbits and guinea pigs. In addition, for small animals, there were new releases of an agent (pergolidmesilate) in a novel pharmaceutical formulation and a lower content of the active ingredient, one drug (fluralaner) in a smaller package size as well as one drug (oxalic acid dehydrate) with a new route of administration. Furthermore, one combination of active ingredients (diprophylline+heptaminol) is available on the market for horses and food producing animals again.
2023年，德国市场上没有新的兽用活性药物成分投放于马匹和食用动物。两种已有的兽用活性药物成分被批准用于更多物种：磷化合物布他磷也被批准用于马、狗和猫，矿物质氯化钠作为等渗氯化钠溶液也被批准用于兔子和豚鼠。此外，对于小动物，有一种新型药物制剂中的药物（甲磺酸培高利特）以及活性成分含量较低的药物上市，一种包装尺寸更小的药物（氟虫腈）以及一种具有新给药途径的药物（草酸二水合物）。此外，一种活性成分组合（二羟丙茶碱+庚胺醇）再次投放于德国市场用于马匹和食用动物。
